The FTSE 100 rose on Monday as gains in BP, Shell and defensive stocks helped London equities recover from their steepest weekly decline in more than a month, while investors prepared for a packed week of UK economic data and central-bank decisions.
London’s blue-chip index was up 0.55% at 10,708.76 by 0959 GMT, with energy, pharmaceutical and consumer staples stocks leading the advance. The more domestically focused FTSE 250 moved in the opposite direction, falling 0.4% to 23,878.45 and touching its lowest intraday level in more than a month.
Higher oil prices provided an immediate lift to the FTSE 100, while rising government bond yields and uncertainty surrounding global technology stocks encouraged investors to rotate toward traditionally defensive sectors.
Why Is the FTSE 100 Rising Today?
The FTSE 100 is rising today as strength in oil majors and defensive stocks outweighs weakness across mining shares. Energy stocks gained around 1.1% after oil prices climbed roughly 3%, extending the sharp volatility in crude markets amid renewed concerns over Middle East supply.
BP and Shell shares both rose around 1.1%, making the heavyweight oil producers important contributors to the FTSE 100’s advance. The gains continued a period of relative strength for UK energy stocks. Oil majors also outperformed the broader market last week, helping cushion the FTSE 100 as the index recorded its largest weekly decline in more than a month.
The FTSE’s large exposure to energy companies is proving supportive at a time when higher oil prices are creating renewed inflation concerns elsewhere in global markets.
BP and Shell Shares Rise as Oil Prices Jump 3%
BP shares and Shell shares moved higher on Monday as crude oil prices resumed their advance, with renewed attacks on Saudi Arabian infrastructure and Gulf shipping adding to supply concerns. The roughly 3% increase in crude prices lifted the broader UK energy sector by around 1.1%.
Oil has become an increasingly important driver for the FTSE 100 outlook. Higher crude prices can support earnings expectations for heavyweight energy producers such as BP and Shell, even as they increase inflationary pressure on the broader economy.
That dynamic partly explains why London’s blue-chip index has shown greater resilience than some international markets during the latest increase in energy prices.
GSK Shares Jump 3.7% on Lung Cancer Drug Results
Healthcare stocks provided another major source of support. The UK pharmaceutical sector advanced approximately 2.7%, led by a 3.7% rise in GSK shares after the company reported positive results involving two lung cancer treatments, Jideytro and Ris-Rez. The move made GSK one of the standout FTSE 100 gainers on Monday and strengthened the broader rotation into defensive shares.
Consumer defensive sectors were also firmly higher. Personal care, drug and grocery stocks gained around 2.6%, while beverage stocks advanced approximately 2.8%. The pattern suggests investors are seeking companies whose earnings may prove more resilient if higher borrowing costs and geopolitical uncertainty begin weighing more heavily on global growth.
FTSE 100 Benefits From Shift Toward Defensive Stocks
Monday’s advance is notable because it is not being driven by broad risk appetite. Instead, investors appear to be favouring defensive FTSE 100 stocks as government bond yields rise and uncertainty spreads across global equity markets. British government bond yields moved higher again on Monday, reaching fresh multi-year highs across several maturities.
At the same time, global technology stocks came under pressure following renewed concerns about the pace of artificial-intelligence development. Nasdaq futures fell around 1.8%, highlighting the weaker appetite for growth-sensitive technology shares.
The FTSE 100 has relatively limited exposure to the large technology companies that dominate US indices. Its heavier weighting toward energy, healthcare and consumer staples has therefore provided some insulation from the latest weakness in global technology stocks.
That sector composition is helping London outperform during Monday’s defensive rotation.
Mining Stocks Fall as Metal Prices Retreat
Not every part of the London market participated in Monday’s rebound. Industrial and precious-metals miners were among the biggest percentage decliners as metal prices fell. Weakness in mining stocks limited the FTSE 100’s advance, illustrating the competing forces currently driving the index.
Energy companies are benefiting from higher oil prices, while miners are facing weaker metals markets. At the same time, higher bond yields are making investors more selective about economically sensitive shares.
The divergence also helps explain the weaker performance of the FTSE 250, which lacks the same concentration of multinational oil and pharmaceutical heavyweights supporting the FTSE 100.
GlobalData Shares Plunge 22% as Growth Outlook Disappoints
The sharpest individual move came outside the FTSE 100. GlobalData shares plunged around 22%, sending the stock to the bottom of the FTSE 250 after the data analytics and consulting company warned that annual revenue growth would be weaker than previously expected.
The decline contributed to the FTSE 250’s 0.4% fall and widened Monday’s performance gap between London’s large-cap and mid-cap indices. That divergence is becoming an important feature of the UK market. While the internationally exposed FTSE 100 is benefiting from energy and defensive stocks, domestically sensitive mid-caps remain more exposed to concerns around borrowing costs and the UK economic outlook.
UK Inflation and Bank of England Decision in Focus
The next test for the FTSE 100 will come from a series of major economic releases and central-bank decisions. Investors will receive fresh UK employment and inflation figures before the Bank of England’s interest-rate decision later this week. The BoE is widely expected to leave interest rates unchanged, but markets will be watching its language for clues about how policymakers are balancing inflation risks against economic growth.
Higher oil prices complicate that calculation by threatening to keep headline inflation elevated. UK government bond yields have already moved sharply higher, making incoming inflation data particularly important for interest-rate expectations and rate-sensitive stocks.
Fed Rate Decision Adds to FTSE 100 Volatility Risk
The Bank of England is not the only major central bank in focus. The Federal Reserve announces its interest-rate decision on Wednesday, with markets pricing a high probability of another 25-basis-point increase. The decision could influence global bond yields, the US Dollar and risk appetite across international equity markets.
For the FTSE 100, the reaction may again depend heavily on sectors.
A more hawkish Fed could pressure economically sensitive and growth stocks through higher yields, while renewed demand for defensive shares could favour some of the healthcare and consumer staples companies currently supporting the London index.
FTSE 100 Outlook: Can the Index Extend Its Recovery?
The FTSE 100 outlook has improved at the start of the week, with the index recovering toward 10,700 as energy and defensive stocks attract buyers. The sustainability of the rebound will depend on whether BP, Shell and other heavyweight defensive names can maintain their momentum as investors digest UK economic data and major central-bank decisions.
For now, 10,700 is the immediate area to watch. Holding above that region would help preserve Monday’s recovery, while another deterioration in global risk sentiment could put the index back under pressure.
Oil prices, UK inflation and this week’s Fed and Bank of England decisions are likely to remain the biggest catalysts for the FTSE 100 over the coming sessions.
BP and Shell shares are rising as oil prices climb roughly 3% amid renewed concerns about supply following attacks affecting Saudi Arabian infrastructure and Gulf shipping.
GSK shares gained around 3.7% after the pharmaceutical company announced positive results involving two lung cancer treatments, Jideytro and Ris-Rez.
The FTSE 250 fell around 0.4% as UK mid-cap stocks underperformed the defensive-heavy FTSE 100. GlobalData was among the biggest decliners after plunging approximately 22% on a weaker revenue growth outlook.